Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 1:9:899290.
doi: 10.3389/fcvm.2022.899290. eCollection 2022.

The Systolic Pulmonary Arterial Pressure Liaises Impaired Cardiac Autonomic Control to Pro-inflammatory Status in Systemic Sclerosis Patients

Affiliations

The Systolic Pulmonary Arterial Pressure Liaises Impaired Cardiac Autonomic Control to Pro-inflammatory Status in Systemic Sclerosis Patients

Gabriel D Rodrigues et al. Front Cardiovasc Med. .

Abstract

The current study was undertaken to test the hypothesis that systemic sclerosis (SSc) patients with higher systolic pulmonary arterial pressures (PAPs) present a blunted cardiac autonomic modulation and a pro-inflammatory profile. Thirty-nine SSc patients were enrolled (mean age 57 ± 11 years). ECG and respiration were recorded in the supine (SUP) position and during the active standing (ORT). Heart rate variability (HRV) analysis was performed on samples of 300 beats. The symbolic analysis identified three patterns, 0V%, (sympathetic) and 2UV% and 2LV%, (vagal). The %ΔORT was calculated from the differences between HRV in ORT and SUP, normalized (%) by the HRV values at rest. The PAPs was obtained non-invasively through echocardiography. For the inter-group analysis, participants were allocated in groups with higher (+PAPs ≥ median) and lower PAPs (-PAPs < median) values. At rest, the cardiac sympathetic modulation (represented by 0V%) was positively correlated with PAPs, while parasympathetic modulation (represented by 2LV%) was negatively correlated with PAPs. The dynamic response to ORT (represented by Δ0V% and Δ2LV%), sympathetic and parasympathetic were negatively and positively correlated with PAPs, respectively. The +PAPs group presented a higher inflammatory status and a blunted cardiac autonomic response to ORT (↓Δ0V% and ↑Δ2LV%) compared to the -PAPs group. These findings suggest an interplay among cardiac autonomic control, inflammatory status, and cardiopulmonary mechanics that should be considered for the assessment, monitoring, and treatment of SSc patients.

Keywords: autoimmune diseases; heart rate variability; inflammatory reflex; scleroderma; symbolic analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Correlations between systolic pulmonary artery pressure and cardiac autonomic modulation in SSc patients. PAPs, systolic pulmonary artery pressure; Δ0V%, [(0V% in supine position-0V% in orthostatic position)/0V% in supine position]. 0V% and 2LV% are non-linear heart rate variability markers of sympathetic and vagal modulation. Plots (A,B) represent cardiac sympathetic modulation at rest and sympathetic dynamic response to ORT, respectively. Plots (C,D) represent cardiac vagal modulation at rest and vagal dynamic response to ORT, respectively. *p < 0.05 from Spearman’s correlation.
FIGURE 2
FIGURE 2
Comparisons of dynamic cardiac response to active standing test between –PAPs and +PAPs groups between. PAPs, mean pulmonary artery pressure; PAPs-, PAPs group of PAPs < median; PAPs+, group of PAPs ≥ median; Δ0V%, [(0V% in supine position-0V% in orthostatic position)/0V% in supine position]. 0V% and 2LV% are non-linear heart rate variability markers of sympathetic and vagal modulation. *p < 0.05 from Mann–Whitney U test.

Similar articles

Cited by

References

    1. Ferri C, Emdin M, Giuggioli D, Carpeggiani C, Maielli M, Varga A, et al. Autonomic dysfunction in systemic sclerosis: time and frequency domain 24-hour heart rate variability analysis. Br J Rheumatol. (1997) 36:669–76. 10.1093/rheumatology/36.6.669 - DOI - PubMed
    1. Komócsi A, Vorobcsuk A, Faludi R, Pintér T, Lenkey Z, Költo G, et al. The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology (Oxford). (2012) 51:1027–36. 10.1093/rheumatology/ker357 - DOI - PubMed
    1. Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. Classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum. (2013) 65:2737–47. - PMC - PubMed
    1. Papo M, Cohen-Aubart F, Trefond L, Bauvois A, Amoura Z, Emile J, et al. Systemic histiocytosis (Langerhans cell histiocytosis, Erdheim Chester disease, Destombes Rosai Dorfman disease): from oncogenic mutations to inflammatory disorders. Curr Oncol Rep. (2019) 2:62. 10.1007/s11912-019-0810-6 - DOI - PubMed
    1. Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. (2010) 69:1809–15. 10.1136/ard.2009.114264 - DOI - PubMed